Article
Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancer
2022-08-01
Abstract excerpt
<title>Abstract</title> <p>Background Luminal B breast cancer is routinely treated with chemotherapy and endocrine therapy. However, its sensitivity to treatment remains heterogeneous; therefore, identifying patients who may most benefit, remains crucial. Immune-related genes are reportedly related to the prognosis of breast cancer. The purpose of this study was to evaluate the impact of an immune-related gene s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 560fed90-aaeb-5227-84df-b75b65e56e7d
- DOI
- 10.21203/rs.3.rs-1740378/v1